Martin Shkreli Sentenced to Seven Years in Prison

  • Brash entrepreneur lied to investors to cover fund losses
  • Notorious ‘Pharma Bro’ chokes up in court: ‘This is my fault’
Shkreli outside federal court in the Brooklyn, New York on June 26, 2017.Photographer: Victor J. Blue/Bloomberg
Lock
This article is for subscribers only.

Martin Shkreli, the pharmaceutical industry’s enfant terrible, was sentenced Friday to seven years in prison, putting an end to a saga that captivated and sometimes enraged Washington, Wall Street and the tabloids.

The brash 34-year-old — who gained notoriety for jacking up the price of a life-saving anti-infection drug — was convicted in August of lying to investors in his hedge funds and manipulating shares in Retrophin Inc., a biotech company he founded. Prosecutors sought a sentence of at least 15 years for the securities fraud. Shkreli, who once proclaimed “you can’t quell the Shkrel,” asked for as little as a year.